Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET).
暂无分享,去创建一个
J. Meyerhardt | C. Fuchs | A. Zhu | D. Ryan | E. Kwak | B. Wolpin | T. Abrams | M. Kulke | J. Faris | K. Ng | L. Blaszkowsky | Janet E. Murphy | N. McCleary | Sui Zhang | J. Chan | Bridget Fitzpatrick | A. Reardon